Showing results (51-60 of 180) with videos related to
Sort By:
Pageof 18
International Journal of Oncology|May 14, 2014
HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancerKyung Hee Jung, Hong Hua Yan, Zhenghuan Fang, et al.International Journal of Oncology|April 23, 2013
Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitorSun-Mi Yun, Ju-Hee Lee, Kyung Hee Jung, et al.Archives of Pharmacal Research|May 4, 2012
The effect of HS-111, a novel thiazolamine derivative, on apoptosis and angiogenesis of hepatocellular carcinoma cellsMyung-Joo Choi, Hyunseung Lee, Ju-Hee Lee, et al.Scientific Reports|June 7, 2016
Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxiaEun-Taex Oh, Chan Woo Kim, Soo Jung Kim, et al.Indian Journal of Pharmacology|June 23, 2020
SB365 induces apoptosis and suppresses proliferation of glioblastoma cellsJoo Han Lim, Kyung Hee Jung, Mi-Soon Kim, et al.Journal of Medicinal Chemistry|July 9, 2014
Development and biological evaluation of potent and selective c-KIT(D816V) inhibitorsSoyoung Lee, Hyunseung Lee, Jinhee Kim, et al.Oncology Reports|May 28, 2013
A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cellsHyunseung Lee, Soo Jung Kim, Kyung Hee Jung, et al.Journal of Microencapsulation|August 5, 2014
AAPE proliposomes for topical atopic dermatitis treatmentAlexander Jahn, Chung Kil Song, Prabagar Balakrishnan, et al.FEBS Letters|October 9, 2007
Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alphaHyoung-Oh Jun, Younghwa Kim, Yoo-Wook Kwon, et al.Experimental & Molecular Medicine|September 22, 2018
HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosisHan-Hee Park, Se-Yeon Park, Shinmee Mah, et al.Pageof 18